Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

2017-05-01   Aurelia Meloni-Ehrig 

1.CSI Laboratories, Alpharetta, GA, USA; ameloni@CSIlaboratories.com

Abstract

Review on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), with data on clinics, and the genes involved.

Clinics and Pathology

Phenotype stem cell origin

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic neoplasm. Despite its rarity, there is extensive historic and scientific literature. Since 1994, when this neoplasm was first described (Adachi et al., 1994), BPDCN has been known with various names, including agranular CD4+ natural killer (NK) leukemia, CD4+/CD56+ hematodermic neoplasm, and blastic NK lymphoma (Facchetti et al., 2009; Pilichowska et al., 2007; Petrella et al., 2005; Assaf et al., 2007). In 2008, the WHO has placed this neoplasm in the category of acute myeloid leukemia (AML) and related precursor neoplasms (Facchetti et al., 2008; Swerdlow et al., 2008) following the realization that BPDCN results from the clonal proliferation of immature plasmacytoid dendritic cells (PDC) (Facchetti et al., 2008). In normal situations, the PDC are an essential part of the innate adaptive immunoresponse (Jegalian et al., 2009; Reizis et al., 2011). These cells respond to viral and bacterial infection by producing alpha-interferon. As such, they are also known also as alpha-interferon producing cells or plasmacytoid monocytes. Expansion of the normal PDCs can occur in autoimmune disorders, as well as Hodgkin lymphoma, and various carcinomas. Flow cytometry and immunohistochemistry studies have revealed that the neoplastic PDC of virtually all patients are typically found in the CD45dim blast gate region and are phenotypically defined by the co-expression of CD4, CD56, and CD123, absence of CD34, and lack of specific myeloid-, T-, B-, or NK-lineage markers (Pagano et al., 2013). Very rarely CD56 might not be expressed. In those cases, the expression of CD4, CD123, and TCL1 would be sufficient to suspect BPDCN (Herling et al., 2003). Approximately 50% of the cases might also express CD43, CD45RA, and CD68. Other markers observed less frequently include CD7, HLA-DR, TCL1, CD33, BDCA2/CD303, BDCA4/CD304, CLA, and MxA (Petrella et al., 2004; Pilichowska et al., 2007).

Epidemiology

BPDCN is quite rare; less than 100 cases have been reported so far. The disease does not have a geographic predilection as it has been observed in various countries around the world (Tsagarakis et al., 2010; Qayoom et al., 2015; Assaf et al., 2007). The exact incidence might be difficult to determine due to the various definitions of BPDCN as a leukemia or a skin lymphoma prior to the 2008 WHO inclusion of this neoplasm into the AML and related precursors neoplasms (Facchetti et al., 2008). Recent reports in the incidence, indicate that this neoplasm accounts for 0.4% of all hematologic neoplasms, 0.7% of the primary cutaneous lymphomas, and less than 1% of all acute leukemias (Facchetti et al., 2008; Riaz et al., 2014; Rossi et al., 2006; Pagano et al., 2013). BPDCN has been described in all age groups, but is most common in adults; the majority of patients are older adults and the median age at diagnosis is 65 years. Some patients are younger than 40 years old, and even children with this neoplasm have been reported. The male to female ratio is 3:1.

Clinics

The first symptom in most patients with BPDCN is the presence of multiple cutaneous lesions, often detected incidentally by dermatologists (Gera et al., 2014). As such, histologic diagnosis is required to distinguish BPDCN from other primary skin lesions or other leukemias and lymphomas characterized by cutaneous involvement (Gera et al., 2014). At the same time, or soon after, involvement of bone marrow and/or peripheral blood occurs. This involvement is thought to occur in approximately 90% of the cases. Lymph nodes might also be involved (approximately 50% of the cases). Overt leukemia is a common feature of BPDC during progression or relapse, often with a myelomonocytic phenotype, and is nearly always present in the terminal stage of the disease. However, a minority of patients (5-10% of cases) do not have cutaneous lesions, but present with a very aggressive (fulminant) leukemia (Wang et al., 2012; Rauh et al., 2012; Qayoom et al., 2015). In addition to the typically sites of involvement, other unusual sites might be also affected. Paluri et al. (2015) reported a patient diagnosed with a BPDCN confined to the sinonasal region and central nervous system (CNS). Although CNS is not typically considered a common site of involvement for BPDCN, a recent study has reported a frequent CNS involvement in their group of patients suggesting that the CNS might be a safe reservoir of blast cells in patients with leukemic presentation, due to the fact that drugs are unable to cross the blood-brain barrier (Martin-Martin et al., 2016). Regardless of the presentation, the overall prognosis for patients with BPDCN is unfavorable, with a median overall survival of approximately one year (Facchetti et al., 2008; Julia et al., 2013). In children, BPDCN is characterized by less frequent cutaneous involvement and a significant response to intensive acute lymphoblastic leukemia (ALL)-type chemotherapy, allowing patients to reach complete remission. The overall prognosis and long-term survival in pediatric patients is better than in adults. Some reports made the suggestion that childhood BPDCN might represent a different neoplasm than the one seen in adults (Jegalian et al., 2010; Rossi et al., 2006).
Atlas Image
Immunohistologic studies on lymph node sections show reactivity for CD56 and CD43 and lack reactivity for CD45 and TdT (original magnification ×375). Image available at Blastic plasmacytoid dendritic cell neoplasm. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/lymphomanonBblasticplasmacytoid.html. Accessed April 30th, 2017

Cytology

Examination of BPDCN patients with skin presentation reveals that the neoplasm involves the entire dermis and may extend to the subcutis, but not the epidermis (Gera et al., 2014. When the bone marrow is affected, there is a variable degree of involvement with variable dysplasia. The lymph nodes show a diffuse interfollicular and medullary involvement. Microscopic examination of the skin biopsy typically shows a diffuse monotonous infiltrate of intermediate-sized blast cells with round to oval nuclei and nucleoli, and scant agranular cytoplasm that resemble myeloid blasts, but with NK cell lineage differentiation (Ferreira et al., 2016; Ru et al., 2014). Intracytoplasmic microvacuoles are present in the majority of cases (Ferreira et al., 2016). The mitotic activity is variable.
Atlas Image
(A) Lymph node biopsy. Monomorphous infiltrate of medium-sized cells with scant cytoplasm, round nuclear contours, finely granular chromatin, and numerous mitotic figures (hematoxylin-eosin, original magnification ×375); (B) Bone marrow core biopsy specimen. Hypercellular marrow with trilineage hematopoiesis and an interstitial infiltrate of immature blast-like cells (hematoxylin-eosin, original magnification ×375). (C) Peripheral blood smear after bone marrow transplantation. Immature blasts with high nuclear-to-cytoplasmic ratio, agranular cytoplasm, and round nuclear contours (Wright-Giemsa, original magnification ×500). Image available at Blastic plasmacytoid dendritic cell neoplasm. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/lymphomanonBblasticplasmacytoid.html. Accessed April 30th, 2017

Prognosis

BPDCNA is an aggressive neoplasm with a median survival of approximately 12 months and typically poor response to chemotherapy (Facchetti et al., 2008; Julia et al., 2013). Patients with the leukemic form of the neoplasm have a shorter survival (approximately 8 months) (Riaz et al., 2014). Since skin presentation occurs in the majority of patients, the first therapeutic approach is targeted to treat the skin lesions. There is no specific induction therapy designed specifically to treat this neoplasm. Patients have been treated with existing therapies typically used for non-Hodgkin lymphoma, AML, and ALL (Falcone et al., 2016). Various AML and ALL therapeutic protocols have been used. The AML protocol consists of variable combinations of cytarabine, etoposide, idarubicin, anthracycline, fludarabine, and filgrastim, whereas the ALL protocol includes variable combinations of cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, cytarabine, prednisone, asparaginase, and CHOP with and without etoposide (Pagano et al., 2013). Approximately 90% of patients seem to respond initially to these therapies, but the disease later recurs in the majority of patients (Bayerl et al., 2002). However, Voelkl et al. (2011) reported an elderly patient with BPDCN with AML presentation and skin lesions who achieved a 26 month long remission after treatment with dose intensive multiagent chemotherapy. Long lasting remissions might occur in pediatric patients with good response to acute leukemia chemotherapy and allogeneic stem cell transplantation (Paluri et al., 2015; Male et al., 2010). Several studies have demonstrated that allogeneic stem cell transplantation following a reduced intensity conditioning (avoidance of high-dose therapy) offers the best chance for long lasting remission, particularly when performed during the first complete remission, and suggests that this form of therapy should be pursued aggressively for all BPDCN patients (Dietrich et al. 2011; Roos-Weil et al., 2013; Aoki et al., 2015). There are also clinical trials presently being conducted that are showing promising results. One of these trials consists in the administration of a single cycle of therapy of SL-401. This is a recombinant human interleukin 3a protein conjugated with truncated diphtheria a-toxin DT388-IL3, a potent inhibitor of protein synthesis (Stemline Therapeutics) (Frankel et al., 2014; Fitzgerald et al., 2014). The other clinical trial consists of a targeted therapy against CD56+ tumors. The drug in in this case is lorvotuzumab mertansine, which has been used to targets other hematologic neoplasms that express CD56 (Whiteman et al., 2014).

Cytogenetics

Atlas Image
G-banded karyotype of a patient with BPDCN: 44,XY,del(5)(q15q33),del(6)(q13q23),add(9)(p13),add(12)(p11.2),-13,-15, add(17)(p12). Hypodiploidy with deletions of 5q, 6q, 9p, 12p, and 17p is a common finding. Typically these karyotypes also show loss of chromosome 13 and 15, as seen in this case.

Genes Involved and Proteins

Note
In addition to the loss of tumor suppressor genes due to the various chromosome deletions mentioned in the cytogenetic section (i.e., CDKN1B, RB1, CDKN2A/CDKN2B, and IKZF1), several mutations involving oncogenes have been described. The most common are TET2 at 4q24 (57%), ZRSR2 at Xp22.2 (57%), TP53 at 17p13.2 (14%), and ASXL1 at 20q11.2 (Jardin et al., 2011; Alayed et al., 2013). Exome sequencing has also revealed mutations of other less common genes such as IKZF3 at 17q12, HOXB9at 17q21.3, UBE2G2 at 21q22.3 and ZEB2 at 2q22.3 (Menezes et al., 2014). Furthermore, some patients were found to have a FLT3-ITD mutation (Pagano et al. 2013).

Highly cited references

Pubmed IDYearTitleCitations
357373962022A Novel Ratio Probe Based on Mixing of Thiocyanuric Acid Enhanced Silver Nanoclusters with N, S Co-Doped Carbon Quantum Dots for Detecting Sodium 2,3-Dimercapto Propanesulfonic Acid.0
357361202022Comparative Analysis of Transcriptomes of Ophiostoma novo-ulmi ssp. americana Colonizing Resistant or Sensitive Genotypes of American Elm.0
357359302022Collagenase Administration into Periodontal Ligament Reduces the Forces Required for Tooth Extraction in an Ex situ Porcine Jaw Model.0
357305422022Exploring Characteristics of Homicide Offenders With Schizophrenia Spectrum Disorders Via Machine Learning.0
357297472022Aurivillius Phase Bi4V3O12 with d1 Magnetic Cations, Anisotropic and Negative Thermal Expansion, Multiple Structural Transitions, and Low-Dimensional Magnetism.0
357296122022A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Malawi.0
357294742022Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2.0
357293822022Exploring associations between urine levels of phthalates and autism spectrum disorder symptoms: a case-control study in Tianjin, China.0
357291562022circ_0003204 regulates the osteogenic differentiation of human adipose-derived stem cells via miR-370-3p/HDAC4 axis.0
357277632022Differences in prevalence and risk factors of non-communicable diseases between young people living with HIV (YLWH) and young general population in Cambodia.0
357213242022The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment.0
357196012022Mediating Role of Optimism Bias and Risk Perception Between Emotional Intelligence and Decision-Making: A Serial Mediation Model.0
357189962022Real-world study on HBsAg loss of combination therapy in HBeAg-negative chronic hepatitis B patients.0
357177142022Exposure to surrounding greenness and natural-cause and cause-specific mortality in the ELAPSE pooled cohort.0
357161192022Demethylzeylasteral reduces the level of proteinuria in diabetic nephropathy: Screening of network pharmacology and verification by animal experiment.0
357147622022Factors Associated With Exclusive Direct Breastfeeding in the First 3 Months.0
357136822022Plant Host Traits Mediated by Foliar Fungal Symbionts and Secondary Metabolites.0
357112382022Association Between Increased Lipid Profiles and Risk of Diabetic Retinopathy in a Population-Based Case-Control Study.0
357109152022Cluster analysis categorizes five phenotypes of pulmonary tuberculosis.0
357108472022Activity of isoflavone biochanin A in chronic experimental toxoplasmosis: impact on inflammation.0
357103652022Effect of prone position in patients with acute respiratory distress syndrome supported by venovenous extracorporeal membrane oxygenation: a retrospective cohort study.0
357103532022miRNA-mRNA analysis of sheep adrenal glands reveals the network regulating reproduction.0
357098432022Performance evaluation of activated carbon sorbents for indoor air purification during normal and wildfire events.0
357048522022Objective Cognitive Outcomes and Subjective Emotional Sequelae in Litigating Adults with a Traumatic Brain Injury: The Impact of Performance and Symptom Validity Measures.0
356970942022Impact of Implementation of the Maternal Fetal Triage Index on Patients Presenting with Severe Hypertension.0
356885552022Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.0
356768922022Determination of the Fear of COVID-19 and the Quality of Life of Patients With Transcatheter Aortic Valve Implants During the Pandemic.0
356730392022Impact of COVID-19 Pandemic on Telehealth and In-Person Visits: Implications from an Emergency Department in Argentina.0
356728162022Improving intervention design to promote cervical cancer screening among hard-to-reach women: assessing beliefs and predicting individual attendance probabilities in Bogotá, Colombia.0
356719192022The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence.0
356717152022Structural ordering at magnetic seeds with twins at boundaries of a core-shell alloy Mn60Bi40 and tailored magnetic properties.0
356685102022Factors affecting retention of veterinary practitioners in Ireland: a cross-sectional study with a focus on clinical practice.0
356658882022Adsorption of Co(II) ions using Zr-Ca-Mg and Ti-Ca-Mg phosphates: adsorption modeling and mechanistic aspects.0
356654692022Tuning the Photometric Properties of Ternary Sm3+ Complexes Involving Mixed-Ligands.0
356593162022Travel-Related Diseases and Injuries in Children and Adolescents: A Post-Travel Surveillance Questionnaire Assessment.0
356535122022MRI Screening after Silicone Implant Breast Surgery: Patient Survey of Adherence to FDA Recommendations.0
356527512022Formation of Stilbene Azo-Dimer by Direct Irradiation of p-Azidostilbene.0
356512922022Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma.0
356370672022Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.0
356364672022Carbon dioxide rises beyond acceptable safety levels in children under nose and mouth covering: Results of an experimental measurement study in healthy children.0
356116122022The long non-coding RNA MEG8 induces an endothelial barrier through regulation of microRNA-370 and -494 processing.0
355970732022A novel solar-powered electrochemical mineralization system for persistent remediation of uranium-contaminated groundwater.0
355948162022Water activity influence on the simultaneous production of DON, 3-ADON and 15-ADON by a strain of Fusarium graminearum ss of 15-ADON genotype.0
355804782022A cross-over study of postprandial effects from moist snuff and red wine on metabolic rate, appetite-related hormones and glucose.0
355678412022A holistic assessment of the use of emerging recycled concrete aggregates after a destructive earthquake: Mechanical, economic and environmental.0
355619302022Accurate observation of black and brown carbon in atmospheric fine particles via a versatile aerosol concentration enrichment system (VACES).0
355493522022Recommendations from Cochrane reviews for improving future trials on anesthesia and pain: a meta-research study.0
354905902022Novel Dy incorporated Ca3Y2B4O12 phosphor: Insights into the structure, broadband emission, photoluminescence and cathodoluminescence characteristics.0
354893182022Enhancing thermal and emulsifying resilience of pomegranate fruit protein with gum Arabic conjugation.0
354139862022Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option.0
353829432022The local soft tissue status and the prediction of local complications following fractures of the ankle region.0
353814232022The role of detectability in the evolution of avian-dispersed fruit color.0
353790812022The global lung function initiative 2021 (GLI-2021) norms provide mixed results for static lung volumes (SLVs) in Algerian adults.0
353645992022Achieving Antiretroviral Therapy Uptake and Viral Suppression Among Children and Adolescents Living With HIV in the UNAIDS 90-90-90 Era Across Six Countries in Eastern and Southern Africa-Lessons From the BIPAI Network.0
353615222022Prognostic value of the optimal measurement location of on-site CT-derived fractional flow reserve.0
353515122022The impact of urban environmental exposures on health: An assessment of the attributable mortality burden in Sao Paulo city, Brazil.0
353387692022Long non-coding RNA long intergenic non-protein coding RNA 1232 promotes cell proliferation, migration and invasion in bladder cancer via modulating miR-370-5p/PIM3 axis.0
353318592022Different changes in the biomarker C-terminal telopeptides of type II collagen (CTX-II) following intra-articular injection of high molecular weight hyaluronic acid and oral non-steroidal anti-inflammatory drugs in patients with knee osteoarthritis: a multi-center randomized controlled study.0
352928402022The role of miR-370 and miR-138 in the regulation of BMP2 suppressor gene expression in colorectal cancer: preliminary studies.0
351822782022Da Vinci SP robotic approach to colorectal surgery: two specific indications and short-term results.0
351335342022Regional genotypic variations in normosmic congenital hypogonadotropic hypogonadism: our experience and systematic review.0
351137752022Factors impacting COVID-19 vaccination intention among medical students.0
351132172022Impact of Anthropogenic Pressure on Physico-chemical Characteristics of Forest Soils of Kashmir Himalaya.0
350634642022Medium-term Clinical Efficacy and Complications of Plasmakinetic Enucleation of the Prostate Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.0
349716122022Ohio survey data assessing perceptions of abortion safety.0
349676982022Assessment of automated craving across substances and across cultures: stability-analysis of the Craving Automated Scale (CAS).0
347097112022Patient satisfaction with the first contact physiotherapy service: Results from the national evaluation survey.0
343847272022Predictors of disaster preparedness among registered nurses in Saudi Arabia: A structural equation modelling analysis.0
342699902022Migration and the Health of Non-migrant Family: Findings from the Jamaica Return(ed) Migrants Study.0
340529472022Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.0
333173842022Cost Avoidance Analysis of Medication Conversions on the Treatment of Gastroesophageal Reflux Disease in a Medication Therapy Management Call Center: A Budgetary Perspective.0
331157972022Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease.1
328386382022Identification and analysis of miRNAs in the normal and fatty liver from the Holstein dairy cow.1
326393792022Effect of Augmented Feedback on Velocity Performance During Strength-Oriented and Power-Oriented Resistance Training Sessions.0
357382362022Prediction of Motor Outcome of Stroke Patients Using a Deep Learning Algorithm with Brain MRI as Input Data.0
357366582022Myelosuppression Rates with Administration of Nafcillin with and without Rifampin in Pediatric Patients.0
357359412022Feasibility study of the prevalence of latent tuberculosis infection for Māori in the Waikato region, Aotearoa New Zealand.0
357358092022Evaluation of the Appropriate Use of Coronary Computed Tomography Angiography: A Retrospective, Single-Center Analysis.0
357266122022Light availability in the cultivation environment and the action of glyphosate on Digitaria insularis: physiological aspects and herbicide root exudation.0
357157372022Genome-wide association mapping and genomic prediction for pre‑harvest sprouting resistance, low α-amylase and seed color in Iranian bread wheat.0
357251512022Highly branched starch accelerates the restoration of edible quality of dried rice noodles during rehydration.0
357237022022Comparison of hidden blood loss and clinical efficacy of percutaneous endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion.0
357178172022Clays play a catalytic role in pyrolytic treatment of crude-oil contaminated soils that is enhanced by ion-exchanged transition metals.0
357164142022Influential mechanism of water occurrence states of waste-activated sludge: Over-focused significance of cell lysis to bound water reduction.0
357158912022Global incidence of young-onset dementia: A systematic review and meta-analysis.0
357090432022Nonlinearity-aware PS-PAM-16 transmission for C-band net-300-Gbit/s/λ short-reach optical interconnects with a single DAC.0
357083592022Comparison of specimen quality among the standard suction, slow-pull, and wet suction techniques for EUS-FNA: A multicenter, prospective, randomized controlled trial.0
357052602022Association between intelligence quotient scores and body mass index in pediatric multiple sclerosis.0
357037922022Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm.0
357019932022Differential circRNA and mRNA Expression Profiling During Osteogenic Differentiation in Rat Bone Marrow Mesenchymal Stem Cells.0
357016322022Parenting experiences of cancer patients with minor children and their conversations about the possibility of death: a cross-sectional web-based survey for an online cancer community.0
356998632022A novel epithelial-mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma.0
356988782022Implementing microwell slides for detection and isolation of single circulating tumor cells from complex cell suspensions.0
356983912022A xylan from the fresh leaves of Piper betle: Structural characterization and studies of bioactive properties.0
356947902022Reduction in hospital length of stay and increased utilization of telemedicine during the "return-to-normal" period of the COVID-19 pandemic does not adversely influence early clinical outcomes in patients undergoing total hip replacement: a case-control study.0
356891882022Impulsive Lifestyle Counselling versus treatment as usual to reduce offending in people with co-occurring antisocial personality disorder and substance use disorder: a post hoc analysis.0
356873372022Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019.0
356872632022Role of M2 macrophages-derived extracellular vesicles in IL-1β-stimulated chondrocyte proliferation and inflammatory responses.0
356867112022Long-term Effects of Riboflavin Ultraviolet-A-Induced CXL With Different Irradiances on the Biomechanics of In Vivo Rabbit Corneas.0
356864692022Noninvasive Hemoglobin Measurement Reduce Invasive Procedures in Thalassemia Patients.0

Bibliography

Pubmed IDLast YearTitleAuthors
75266801994High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma.Adachi M et al
239400842013TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.Alayed K et al
259183452015Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm.Aoki T et al
170186832007CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.Assaf C et al
117897292002Blastic natural killer cell lymphoma/leukemia: a report of seven cases.Bayerl MG et al
212158132011Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity.Dietrich S et al
170681542007Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities.Dijkman R et al
267434772016Neoplasms derived from plasmacytoid dendritic cells.Facchetti F et al
278236442016A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm.Falcone U et al
266183042016Cytomorphological features of blastic plasmacytoid dendritic cell neoplasm on FNA and cerebrospinal fluid cytology: A review of 6 cases.Ferreira J et al
250351452014Targeted diphtheria toxin to treat BPDCN.FitzGerald DJ et al
248593662014Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.Frankel AE et al
242475742014Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.Gera S et al
125763132003TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.Herling M et al
212759692011TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm.Jardin F et al
198511302009Plasmacytoid dendritic cells: physiologic roles and pathologic states.Jegalian AG et al
236468682013Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.Julia F et al
273747172016Acute Myeloid Leukemia With MLL Rearrangement and CD4+/CD56+ Expression can be Misdiagnosed as Blastic Plasmacytoid Dendritic Cell Neoplasm: Two Case Reports.Lee JM et al
120108202002CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.Leroux D et al
164269292006CD4+/CD56+ hematologic malignancy with rearranged MLL gene.Leung R et al
219002002011Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.Lucioni M et al
206978542010Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission.Male HJ et al
268400872016Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy.Martín-Martín L et al
240721002014Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.Menezes J et al
223619142012Loss of genomic DNA copy numbers in the p18, p16, p27 and RB loci in blastic plasmacytoid dendritic cell neoplasm.Oiso N et al
230655212013Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.Pagano L et al
248501722015Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.Paluri R et al
153231482004TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.Petrella T et al
177093192007CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.Pilichowska ME et al
262752712015Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous involvement in a 25 years male patient: Unusual presentation of a rare entity.Qayoom S et al
218901992012Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.Rauh MJ et al
212191842011Plasmacytoid dendritic cells: recent progress and open questions.Reizis B et al
253102092014Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.Riaz W et al
232038222013Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation.Roos-Weil D et al
166905312006Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome.Rossi JG et al
239573702014Morphologic characteristics of blastic plasmacytoid dendritic cell neoplasm: a case report.Ru Y et al
218314282012The first case of blastic plasmacytoid dendritic cell neoplasm with MLL-ENL rearrangement.Toya T et al
197936122010Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.Tsagarakis NJ et al
211676002011Blastic plasmacytoid dendritic cell neoplasm with acute myeloid leukemia successfully treated to a remission currently of 26 months duration.Voelkl A et al
222368702012Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review.Wang H et al
244923072014Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models.Whiteman KR et al
261643982015KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.Yang N et al

Citation

Aurelia Meloni-Ehrig

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Atlas Genet Cytogenet Oncol Haematol. 2017-05-01

Online version: http://atlasgeneticsoncology.org/haematological/2146/blastic-plasmacytoid-dendritic-cell-neoplasm-(bpdcn)

External Links